 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that AADI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Aadi Bioscience (AADI, $5.24) RSI Indicator left the overbought zone on November 30, 2023

Aadi Bioscience (AADI, $5.41) RSI Indicator left the overbought zone on November 28, 2023

This price move could be a signal that AADI may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Aadi Bioscience (AADI, $5.41) price may drop as it broke higher Bollinger Band on Nov 28, 2023

AADI's total volume now sits at 408.2K. The +0.64% price change was insignificant, leaving IBM's price at $4.75...

The volume for Aadi Bioscience stock increased for one day, resulting in a record-breaking daily growth of 267% of the 65-Day Volume Moving Average

This price move could indicate a change in the trend, and may be a sell signal for investors...

Aadi Bioscience (AADI, $4.53) price exceeded its 50-day Moving Average on November 16, 2023

This indicator may be signaling that AADI's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Aadi Bioscience (AADI, $4.53) entered Downtrend as Momentum indicator drops below 0 level on Nov 16, 2023

Aadi Bioscience, Inc. (NASDAQ:AADI  Free Report)  Stock analysts at HC Wainwright raised their FY2023 EPS estimates for shares of Aadi Bioscience in a research note issued to investors...

Aadi Bioscience, Inc. Expected to Earn FY2023 Earnings of ($2.46) Per Share (NASDAQ:AADI)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aadi Bioscience price target lowered to $36 from $45 at H.C. Wainwright

TD Cowen analyst Boris Peaker has maintained their bullish stance on AADI stock, giving a Buy rating on October 23. Boris Peaker's buy rating on Aa...

Buy Rating on Aadi Bioscience: Evaluating FYARRO Sales, PRECISION 1 Enrollment Progress, and Potential Market Expansion Opportunities

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update...

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.

Watchers	6,448
52-Wk Low	$3.88
52-Wk High	$13.60

Market Cap	$131.21M
Volume (M)	95,660.00
52-Wk High	$13.60
52-Wk Low	$3.88

AADI Aadi Bioscience Inc

About

Feed

News

Earnings

Fundamentals